Embryonic vaccines against cancer: An early history

Experimental and Molecular Pathology

Volumn 86, Issue 3, 2009, Pages 192-197

  Brewer, Bradley G ^a   Mitchell, Robert A ^a,b   Harandi, Amir ^a,b   Eaton, John W ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Anti cancer immunity; Carcinoembryonic antigens; Embryonic antigens

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; ALPHA FETOPROTEIN; ANTIGEN; CANCER TESTIS ANTIGEN; CANCER VACCINE; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; HUMAN PLACENTA LACTOGEN; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN EXPRESSION; ANTIGENICITY; EMBRYONIC STEM CELL; HUMAN; NEOPLASM; NONHUMAN; PREGNANCY; REVIEW; TUMOR IMMUNITY; VACCINATION;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; EMBRYONIC STEM CELLS; FEMALE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NEOPLASMS; PREGNANCY;

ANIMALIA;

EID: 67349115733     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2008.12.002     Document Type: Review

References (107)

1. Abelev G.I. Alpha-fetoprotein in oncogenesis and its association with malignant tumors. Adv. Cancer Res. 14 (1971) 294-358
2. Abelev G.I., Perova S.D., Khramkova N.I., Postnikova Z.A., and Irlin I.S. Production of embyronal α-globulin by transplantable mouse hepatomas. Transplantation 1 (1963) 174-180
3. Alexander P. A cross-reacting fetal antigen in primary chemically induced sarcomas of rats and its relation to immunotherapy. In: Anderson N.G., and Coggin Jr. J.H. (Eds). Proceedings of the First Conference and Workshop on Embryonic and Fetal Antigens in Cancer. Reproduced by National Technical Information Service (1971), U. S. Department of Commerce, Springfield, VA 217-221
4. Alexander P. Foetal antigens in cancer. Nature 235 (1972) 137-140
5. Alexander P., and Fairley G.H. Cellular resistance to tumors. Br. Med. Bull. 23 (1967) 86-92
6. Ambrose K.R., Candler E.L., and Coggin Jr. J.H. Characterization of tumor-specific transplantation immunity reactions in immunodiffusion chambers in vivo. Proc. Soc. Ex. Biol. Med. 132 (1969) 1013-1020
7. Ambrose K.R., Anderson N.G., and Coggin Jr. J.H. Cytostatic antibody and SV40 tumour immunity in hamsters. Nature 233 (1971) 321-324
8. Ambrose K.R., Anderson N.G., and Coggin Jr. J.H. Interruption of SV40 oncogenesis with human foetal antigen. Nature 233 (1971) 194-195
9. Ayyoub M., Brehm M., Metthez G., et al. SSX antigens as tumor vaccine targets in human sarcoma. Cancer Immun. 3 (2003) 13
10. Baldwin R.W., and Barker C.R. Antigenic composition of transplanted rat hepatomas originally induced by 4-dimethylaminoazobenzene. Br. J. Cancer 21 (1967) 338-345
11. Baldwin R.W., Glaves D., and Vose B.M. Embryonic antigen expression in chemically induced rat hepatomas and sarcomas. Int. J. Cancer 10 (1972) 233-243
12. Baldwin R.W., Glaves D., and Vose B.M. Fetal antigen expression on chemically induced rat neoplasms. In: Anderson N.G., Coggin Jr. J.H., Cole E., et al. (Eds). Embryonic and Fetal Antigens in Cancer Vol. 2 (1972), U. S. Atomic Energy Commission Technical Information Center, Oak Ridge, Tennessee 193-198
13. Baldwin R.W., Glaves D., Pimm M.V., and Vose B.M. Tumour specific and embryonic antigen expression on chemically induced rat tumours. Ann. Inst. Pasteur 122 (1972) 715-728
14. Baldwin R.W., Embleton M.J., and Robins R.A. Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status. Int. J. Cancer 11 (1973) 1-10
15. Baranska W., Koldovsky P., and Koprowski H. Antigenic study of unfertilized mouse eggs: cross reactivity with SV40-induced antigens. Proc. Natl. Acad. Sci. U. S. A. 67 (1970) 193-199
16. Bendich A., Borenfreund E., and Stonehill E.H. Protection of adult mice against tumor challenge by immunization with irradiated adult skin or embryo cells. J. Immunol. 111 (1973) 284-285
17. Borsos T., Richardson A.K., Ohanian S.H., and Leonard E.J. Immunochemical detection of tumor-specific and embryonic antigens of diethylnitrosamine-induced guinea pig tumors. J. Nat. Cancer Inst. 51 (1973) 1955-1960
18. Brawn R.J. Possible association of embryonal antigen(s) with several primary 3-methylcholanthrene-induced murine sarcomas. Int. J. Cancer 6 (1970) 245-249
19. Burtin P., Von Kleist S., and Sabine M.C. Loss of a normal colonic membrane antigen in human cancers of the colon. Cancer Res. 31 (1971) 1038-1041
20. Buttle G.A.H., and Frayn A. Effect of previous injection of homologous embryonic tissue on the growth of certain transplantable mouse tumours. Nature 215 (1967) 1495-1497
21. Buttle G.A.H., Eperon J., and Menzies D.N. Induced tumour resistance in rats. Lancet 2 (1964) 12-14
22. Ceppellini R., Bonnard G.D., Coppo F., Miggiano V.C., Popisil M., Curtoni E.S., et al. Transplantation antigens: introductory symposium. Mixed leukocyte cultures and HL-A antigens. I. Reactivity of young fetuses, newborns and mothers at delivery. Transplant. Proc. 3 (1971) 58-63
23. Coggin Jr. J.H., and Ambrose K.R. A rapid in vivo assay for SV40 tumor immunity in hamsters. Proc. Soc. Exp. Biol. Med. 130 (1969) 246-252
24. Coggin Jr. J.H., Larson V.M., and Hilleman M.R. Immunologic response in hamsters to homologous tumor antigens measured in vivo and in vitro. Proc. Soc. Exp. Biol. Med. 24 (1969) 1295-1302
25. Coggin Jr. J.H., Ambrose K.R., and Anderson N.G. Fetal antigen capable of inducing transplantation immunity against SV40 hamster tumor cells. J. Immunol. 105 (1970) 524-526
26. Coggin Jr. J.H., Ambrose K.R., and Anderson N.G. Immunization against tumors with fetal antigens. In: Anderson N.G., and Coggin Jr. J.H. (Eds). Proceedings of the First Conference and Workshop on Embryonic and Fetal Antigens in Cancer. Reproduced by National Technical Information Service (1971), U. S. Department of Commerce, Springfield, VA 7-35
27. Coggin Jr. J.H., Ambrose K.R., Bellomy B.B., and Anderson N.G. Tumor immunity in hamsters immunized with fetal tissues. J. Immunol. 107 (1971) 526-533
28. Colnaghi M.I., and Della Porta G. Evidence for virus-related and unrelated antigens on murine lymphomas induced by chemical carcinogens. J. Natl. Cancer Inst. 50 (1973) 173-180
29. Conheim J. Vorlesungen über allgemeine Pathologie. Ein Hanbuch fur Aerzte und Studirende Vol. 2 (1880), Hirschwald, Berlin 634-654
30. Dao T.L., Bock F.G., and Greiner M.J. Mammary carcinogenesis by 3-methylcholanthrene. II. Inhibitory effect of pregnancy and lactation on tumor induction. J. Natl. Cancer Inst. 25 (1960) 991-1003
31. DeBroe M.E., and Pollet D.C. Multicenter evaluation of human placental alkaline phosphatase as a possible tumor-associated antigen in serum. Clin. Chem. 34 (1988) 1995-1999
32. Deichman G.I. Immunological aspects of carcinogenesis by deoxyribonucleic acid tumor viruses. Adv. Cancer Res. 12 (1969) 101-136
33. Dierlam P., Anderson N.G., and Coggin Jr. J.H. In: Anderson N.G., and Coggin Jr. J.H. (Eds). Proceedings of the First Conference and Workshop on Embryonic and Fetal Antigens in Cancer. Reproduced by National Technical Information Service (1971), U. S. Department of Commerce, Springfield, VA 203-221
34. Duff R.J., and Rapp F.J. Reaction of serum from pregnant hamsters with surface of cells transformed by SV40. J. Immunol. 105 (1970) 521-523
35. Durante, F., 1874. Nesso Fisi-patologico tra la Struttura dei Nei Materni e la Genesi di alcuni Tumori Maligni. Archivio di Memorie ed Ossevazione di Chirurgia Practica (per F. Palasciano). Napoli: Gennaro a Decembre, 1874, pp. 217-226.
36. Durkop H., Foss H.D., Eitelbach F., et al. Expression of the CD30 antigen in non-lymphoid tissues and cells. J. Pathol. 190 (2000) 613-618
37. Edidin M., Patthey H.L., McGuire E.J., and Sheffield W.D. An antiserum to "embryoid body" tumor cells that reacts with normal mouse embryos. In: Anderson N.G., and Coggin Jr. J.H. (Eds). Proceedings of the First Conference and Workshop on Embryonic and Fetal Antigens in Cancer. Reproduced by National Technical Information Service 1 (1971), U. S. Department of Commerce, Springfield, VA 239-247
38. Eifuku R., Takenoyama M., Yoshino I., et al. Analysis of MAGE-3 derived synthetic peptide as a human lung cancer antigen recognized by cytotoxic T lymphocytes. Int. J. Clin. Oncol. 6 (2001) 34-39
39. Fibiger J., and Moeller P. Reserches sur l'ummunisation contre la formation de metastases dans le cancer experimental. Acta Pathol. Microbiol. Scand. 4 (1927) 136-162
40. Fishman W.H., Raam S., and Stolbach L.L. Markers for ovarian cancer: Regan isoenzyme and other glycoproteins. Semin. Oncol. 2 (1975) 211-216
41. Fraumeni Jr. J.F., Lloyd J.W., Smith E.M., and Wagoner J.K. Cancer mortality among nuns: role of marital status in etiology of neoplastic disease in women. J. Natl. Cancer Inst. 2 (1969) 455-468
42. Freedman S.O., Gold P., Krupey J., and Machado H.C. Human tumor antigens. In: Morgan J.F. (Ed). Proceedings of the Eighth Canadian Cancer Research Conference Vol. 8 (1969), Pergamon Press, Oxford 407-424
43. Fuith L.C., Müller-Holzner E., Marth C., et al. Distribution of CA 125 in placental tissues. Int. J. Biol. Markers 4 (1989) 78-80
44. Garin-Chesa P., Campbell I., Saigo P.E., et al. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am. J. Pathol. 142 (1993) 557-567
45. Girardi A.J., Reppucci P., Dierlam P., Rutala W., and Coggin Jr. J.H. Prevention of simian virus 40 tumors by hamster fetal tissue: influence of parity status of donor females on immunogenicity of fetal tissue and on immune cell cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 70 (1973) 183-186
46. Gold P. Circulating antibodies against carcinoembryonic antigens of the human digestive system. Cancer 20 (1967) 1663-1668
47. Grant J.P., and Wells S.A. Tumor resistance in rats immunized with fetal tissues. J. Surg. Res. 16 (1974) 533-540
48. Gu Z., Thomas G., Yamashiro J., et al. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene 19 (2000) 1288-1296
49. Habel K. Immunologic determinants of polyoma virus oncogenesis. J. Exp. Med. 115 (1962) 181-193
50. Habel K. Tumor antigens. In: Morgan J.F. (Ed). Proceedings of the Eighth Canadian Cancer Research Conference Vol, 8 (1969), Pergamon Press, Oxford 390-406
51. Haddow A. Immunology of the cancer cell. Br. Med. Bull. 21 (1965) 133-139
52. Hanna Jr. M.G., Tennant R.W., Coggin Jr. J.H., and Treber J.A. Immunization with mouse fetal antigens: suppressive effect on growth of leukemia virus-infected cells and on plasma cell tumors. In: Anderson N.G., and Coggin Jr. J.H. (Eds). Proceedings of the First Conference and Workshop on Embryonic and Fetal Antigens in Cancer. Reproduced by National Technical Information Service (1971), U. S. Department of Commerce, Springfield, VA 267-278
53. Hanna Jr. M.G., Tennant R.W., and Coggin Jr. J.H. Suppressive effect of immunization with mouse fetal antigens on growth of cells infected with Rauscher leukemia virus and on plasma-cell tumours. Proc. Natl. Acad. Sci. U. S. A. 68 (1971) 1748-1752
54. Haynes W.D., Shertock K.L., Skinner J.M., et al. The ultrastructural immunohistochemistry of oncofetal antigens in large bowel carcinomas. Virchows Arch., A Pathol. Anat. Histopathol. 405 (1985) 263-275
55. Hellström K.E., and Hellström I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv. Immunol. 8 (1973) 209-277
56. Hellström I., Hellström K.E., Evans C.A., Heppner G.H., Pierce G.E., and Yang J.P.S. Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc. Natl. Acad. Sci. U. S. A. 12 (1969) 362-368
57. Hirzfeld L. Untersuchungen über die serologischen Eigenschaften der Gewebe: über serologische Eigenschaften der Neubildungen. Z. Immun.Forsch. Exp. Ther. 64 (1929) 81-113
58. Hirzfeld L., Halber U., and Rosenblat J.C. Verwandtschaftsreaktionen zwischen Embryonal- und Krebsgewebe; Mesenchenembryo und Menschenkrebs. Z. Immunitatsforsch. Exp. Ther. 75 (1932) 209-216
59. Hofman P., His B.L., Manie S., et al. High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?. Breast Cancer Res. Treatment 32 (1994) 213-219
60. Inge T.H., Hoover S.K., Susskind B.M., Barrett S.K., and Bear H.D. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1. Cancer Res. 52 (1992) 1386-1392
61. Jiang X.P., Yang D.C., Elliot R.L., et al. Vaccination with a mixed vaccine of autogenous and allogeneic breast cancer cells and tumor associated antigens CA 15-3, CEA and CA125 results in immune and clinical responses in breast cancer patients. Cancer Biother. Radiopharm. 15 (2000) 495-505
62. Klavins J.V., Mesa-Tejada R., and Weiss M. Human carcinoma antigens cross-reacting with anti-embryonic antibodies. Nat. New Biol. 234 (1971) 153-154
63. Laurence D.J.R., and Neville A.M. Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. Br. J. Cancer 26 (1972) 335-355
64. LeMevel B.P., and Wells Jr. S.A. Foetal antigens cross-reactive with tumour-specific transplantation antigens. Nat. New Biol. 244 (1973) 183-184
65. Luftl M., Schuler G., Jungbluth A.A., et al. Melanoma or not? Cancer testis antigens may help. Br. J. Dermatol. 151 (2004) 1213-1218
66. MacMahon B., Cole P., and Brown J. Etiology of human breast cancer: a review. J. Natl. Cancer Inst. 50 (1973) 21-42
67. McCormick G.M., and Moon R.C. Effect of pregnancy and lactation on growth of mammary tumours induced by 7,12-dimethyl-benz(a)anthracene (DMBA). Br. J. Cancer 16 (1965) 160-166
68. Malatesta M., Mannello F., Luchetti F., et al. Prostate-specific antigen synthesis and secretion by human placenta: a physiological kallikrein source during pregnancy. J. Clin. Endocrinol. Metab. 85 (2000) 317-321
69. Medawar P.B., and Hunt R. Can fetal antigens be used for prophylactic immunization? Ciba Found. Symposium 96 (1983) 160-181
70. Ménard S., Colnaghi M.I., and Della Porta G. In vitro demonstration of tumor-specific common antigens and embryonal antigens on murine fibrosarcomas induced by 7,12- dimethylbenz(a)anthracene. Cancer Res. 33 (1973) 478-481
71. Moon R.C. Relationship between previous reproductive history and chemically induced mammary cancer in rats. Int. J. Cancer 4 (1969) 312-317
72. Morton D.L., Eilber F.R., Joseph W.L., Wood W.C., Trahan E., and Ketcham A.S. Immunological factors in human sarcomas and melanomas. Ann. Surg. 172 (1970) 740-749
73. Müller J. Ueber den feineren Bau und die Formen der Krankhaften Geschwulste (1938), Reimer, Berlin
74. Myers K.A., Rahi-Saund V., Davison M.D., et al. Isolation of a cDNA encoding 5T44 oncofetal trophoblast glycoprotein, an antigen associated with metastasis, contains leucine-rich repeats. J. Biol. Chem. 25 (1994) 9319-9324
75. Nairn R.C., Fothergill J.E., McEntegart M.G., and Richmond H.G. Loss of gastrointestinal-specific antigen in neoplasia. Br. Med. J. (1962) 1791-1793
76. Nakatsura T., Komori H., Kubo T., et al. Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell mediated tumor rejection without autoimmune reactions in mice. Clin. Cancer Res. 10 (2004) 8630-8640
77. Nouri A.M., Torabi-Pour N., and Dabare A.A. A new highly specific monoclonal antibody against placental alkaline phosphatase: a potential marker for the early detection of testis tumor. BJU Int. 86 (2000) 894-900
78. Otto K., Andersen M.H., Eggert A., et al. Lack of toxicity of therapy-induced T cell responses against the universal tumor antigen survivin. Vaccine 23 (2005) 884-889
79. Papadopoulos N., Galazios G., Anastasiadis P., et al. Human decidual cells can express the Hodgkin's cell-associated antigen Ki-1 (CD30) in spontaneous abortions during the first trimester of gestation. Clin. Exp. Obstet. Gynecol. 28 (2001) 225-258
80. Parmiani G., and Lembo R. Studies on the embryonic origin of individual tumor-associated antigens of chemically induced tumors. In: Anderson N.G., Cole J.H., and Holleman J.W. (Eds). Embryonal and Fetal Antigens in Cancer Vol. 2 (1972) 159-165
81. Parmiani G., and Della Porta G. Effects of antitumour immunity on pregnancy in the mouse. Nat. New Biol. 241 (1973) 26-28
82. Pearson G., and Freeman G. Evidence suggesting a relationship between polyoma virus-induced transplantation antigen and normal embryonic antigen. Cancer Res. 28 (1968) 1665-1673
83. Peter H.H., and Feldman J.D. Cell-mediated cytotoxicity during rejection and enhancement of allogeneic skin grafts in rats. J. Exp. Med. 135 (1972) 1301-1315
84. Prehn R.T. The significance of tumor-distinctive histocompatibility antigens. In: Trentin J.J. (Ed). Cross Reacting Antigens and Neoantigens (1967), Williams and Wilkins Co., Baltimore 105-114
85. Prehn R.T. Tumor specific antigens in putatively non-viral tumors. Cancer Res. 28 (1968) 1326-1330
86. Prikler L., Scandella E., Men Y., et al. Adaptive Immunotherapie des fortgeschrittenen Prostatakarzinoms - Cancer Testis Antigene (CTA) als mögliche Zielantigene. Aktuel. Urol. 35 (2004) 326-330
87. Ranges G.E., Figari I.S., Espevik T., and Palladino Jr. M.A. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J. Exp. Med. 166 (1987) 991-998
88. Rees R.C., Price M.R., Baldwin R.W., and Shah L.P. Inhibition of rat lymph node cell cytotoxicity by hepatoma-associated embryonic antigen. Nature 252 (1974) 751-753
89. Rees R.C., Shah L.P., and Baldwin R.W. Inhibition of pulmonary tumour development in rats sensitized to rat embryonic tissue. Nature 255 (1975) 329-330
90. Reinerova M., Veselovaska Z., Ausch C., et al. Immunosuppressive activity of lymphocyte mitogenesis by breast cancer-associated p43. Neoplasma 43 (1996) 363-366
91. Remazzini, B., 1713. De Morbis Artificum, Diatriba (Diseases of Workers). The Latin text of 1713, translated by Wright, W. C. New York: Hafner, 1964, p. 191.
92. Russo J., and Russo I.H. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am. J. Pathol. 100 (1980) 497-512
93. Savory W.S. Bradshaw lecture on the pathology of cancer. Tracts, 172 Royal College of Surgeons of England (1884), Churchill, London 38
94. Scanlan M.J., Gure A.O., and Jungbluth A.A. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol. Rev. 188 (2002) 22-32
95. Schöne G. Untersuchungen über Karzinomimmunität bei Mäusen. Münch. Med. Wochenschr. 51 (1906) 2517-2519
96. Shi Y.Y., Wang H.C., Yin Y.H., et al. Identification and analysis of tumor-associated antigens in hepatocellular carcinoma. Br. J. Cancer 92 (2005) 929-934
97. Skinner J.M., and Whitehead R. Tumor-associated antigens in polyps and carcinoma of the human large bowel. Cancer 47 (1981) 1241-1245
98. Slodowska J., Szturmowicz M., Rudzinski P., et al. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels. Eur. J. Cancer Prev. 7 (1998) 51-60
99. Stanislawski-Birencwajg M., Uriel J., and Grabar P. Association of embryonic antigens with experimentally-induced hepatic lesions in the rat. Cancer Res. 27 (1967) 1991-1997
100. Stonehill E.H., and Bendich A. Retrogenetic expression: the reappearance of embryonal antigens on cancer cells. Nature 228 (1970) 370-372
101. Takasugi M., and Klein E. The role of blocking antibodies in immunological enhancement. Immunology 4 (1971) 675-684
102. Tammela J., Jungbluth A.A., Qian F., et al. SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer. Cancer Immun. 4 (2004) 10
103. Torre-Amione G., Beauchamp R.D., Koeppen H., et al. A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1486-1490
104. Triolo V.A. Nineteenth century foundations of cancer research - advances in tumor pathology, nomenclature and theories of oncogenesis. Cancer Res. 25 (1965) 75-106
105. Tsuruma T., Hata F., Torigoe T., et al. Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer. J. Transl. Med. 2 (2004) 19
106. Weiler E. Loss of specific cell antigen in relation to carcinogenesis. Ciba Foundation Symposium on Carcinogenesis: Mechanism of action (1959), Ciba Foundation, London 165-175
107. Zendman A.J., Van Kraats A.A., Den Hollander A.I., et al. Characterization of XAGE-1b, a short major transcript of cancer/testis-associated gene XAGE-1, induced in melanoma metastasis. Int. J. Cancer 97 (2002) 195-204